Numenor Ventures
Numenor Ventures is a venture capital firm founded in 2002, specializing in seed and early-stage investments. It focuses on life sciences, technology, unique consumer products, fine art, and real estate opportunities, primarily in California, Colorado, Nevada, and the Pacific Northwest. The firm typically takes a board seat in its portfolio companies and offers advisory services.
Top Stages
2 past transactions
AnaptysBio
Series B in 2007
AnaptysBio, Inc. is a clinical-stage biotechnology company based in San Diego, California, dedicated to developing therapeutic antibodies for inflammation and immuno-oncology. The company employs its proprietary somatic hypermutation platform to discover and optimize antibodies that target various diseases. Among its notable product candidates are Etokimab, an anti-IL-33 treatment aimed at conditions such as atopic dermatitis and eosinophilic asthma, and ANB019, an anti-IL-36 receptor for generalized pustular psoriasis. AnaptysBio is also advancing a range of immuno-oncology products, including checkpoint modulators and bispecific antibodies, to address cancer treatment needs. The company collaborates with notable partners like TESARO, Celgene Corporation, and GlaxoSmithKline to enhance its research and development efforts. Founded in 2005, AnaptysBio aims to fulfill unmet medical needs through innovative antibody therapies.
Nutricate
Series A in 2007
Nutricate is a product of SmartReceipt that prints nutritional information on customer receipts, personalized to their specific order. It offers percentage of daily values as well as nutritional facts and suggestions to improve customer health.
Nutricate's parent company, Mobivity, is based in Chandler, AZ.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.